High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Allelic variants at the catechol-O-methyl-transferase (COMT) locus are candidates to contribute to genetic components of interindividual differences in vulnerability to substance abuse. COMT plays a prominent role in dopaminergic circuits important for drug reward, and COMT alleles encode enzymes whose activities vary from three- to four-fold. We compared COMT allele frequencies in control research volunteers reporting insignificant lifetime use of addictive substances with those in volunteers reporting substantial polysubstance use. Homozygosity for the high-activity COMT allele was found in 18% of controls, 31% of volunteers with high lifetime substance use, and 39% meeting DSMIII-R substance abuse criteria [odds ratio (relative risks) 2.0 (control vs. use; 95% confidence interval 1.2-3.5; P < 0.013) and 2.8 (control vs. DSM; 1.3-6.1; P < 0.008)]. Individuals with the high- activity COMT variant may have greater genetic vulnerability to drug abuse.

Original languageEnglish (US)
Pages (from-to)439-442
Number of pages4
JournalAmerican Journal of Medical Genetics - Neuropsychiatric Genetics
Volume74
Issue number4
DOIs
StatePublished - 1997

Fingerprint

Guaiacol
Catechol O-Methyltransferase
Transferases
Alleles
Substance-Related Disorders
Volunteers
Reward
Gene Frequency
Odds Ratio
Confidence Intervals
Enzymes
Research
Pharmaceutical Preparations

Keywords

  • Abuse
  • Cocaine
  • Dopamine
  • Opiates
  • Polymorphism

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)

Cite this

@article{3fa41122fb254f6ba194546611f5d3c7,
title = "High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers",
abstract = "Allelic variants at the catechol-O-methyl-transferase (COMT) locus are candidates to contribute to genetic components of interindividual differences in vulnerability to substance abuse. COMT plays a prominent role in dopaminergic circuits important for drug reward, and COMT alleles encode enzymes whose activities vary from three- to four-fold. We compared COMT allele frequencies in control research volunteers reporting insignificant lifetime use of addictive substances with those in volunteers reporting substantial polysubstance use. Homozygosity for the high-activity COMT allele was found in 18{\%} of controls, 31{\%} of volunteers with high lifetime substance use, and 39{\%} meeting DSMIII-R substance abuse criteria [odds ratio (relative risks) 2.0 (control vs. use; 95{\%} confidence interval 1.2-3.5; P < 0.013) and 2.8 (control vs. DSM; 1.3-6.1; P < 0.008)]. Individuals with the high- activity COMT variant may have greater genetic vulnerability to drug abuse.",
keywords = "Abuse, Cocaine, Dopamine, Opiates, Polymorphism",
author = "Lachman, {Herbert M.}",
year = "1997",
doi = "10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J",
language = "English (US)",
volume = "74",
pages = "439--442",
journal = "American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics",
issn = "1552-4841",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers

AU - Lachman, Herbert M.

PY - 1997

Y1 - 1997

N2 - Allelic variants at the catechol-O-methyl-transferase (COMT) locus are candidates to contribute to genetic components of interindividual differences in vulnerability to substance abuse. COMT plays a prominent role in dopaminergic circuits important for drug reward, and COMT alleles encode enzymes whose activities vary from three- to four-fold. We compared COMT allele frequencies in control research volunteers reporting insignificant lifetime use of addictive substances with those in volunteers reporting substantial polysubstance use. Homozygosity for the high-activity COMT allele was found in 18% of controls, 31% of volunteers with high lifetime substance use, and 39% meeting DSMIII-R substance abuse criteria [odds ratio (relative risks) 2.0 (control vs. use; 95% confidence interval 1.2-3.5; P < 0.013) and 2.8 (control vs. DSM; 1.3-6.1; P < 0.008)]. Individuals with the high- activity COMT variant may have greater genetic vulnerability to drug abuse.

AB - Allelic variants at the catechol-O-methyl-transferase (COMT) locus are candidates to contribute to genetic components of interindividual differences in vulnerability to substance abuse. COMT plays a prominent role in dopaminergic circuits important for drug reward, and COMT alleles encode enzymes whose activities vary from three- to four-fold. We compared COMT allele frequencies in control research volunteers reporting insignificant lifetime use of addictive substances with those in volunteers reporting substantial polysubstance use. Homozygosity for the high-activity COMT allele was found in 18% of controls, 31% of volunteers with high lifetime substance use, and 39% meeting DSMIII-R substance abuse criteria [odds ratio (relative risks) 2.0 (control vs. use; 95% confidence interval 1.2-3.5; P < 0.013) and 2.8 (control vs. DSM; 1.3-6.1; P < 0.008)]. Individuals with the high- activity COMT variant may have greater genetic vulnerability to drug abuse.

KW - Abuse

KW - Cocaine

KW - Dopamine

KW - Opiates

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=0030836682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030836682&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J

DO - 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J

M3 - Article

VL - 74

SP - 439

EP - 442

JO - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

JF - American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

SN - 1552-4841

IS - 4

ER -